Study of the Distribution of High-Risk
Human Papilloma Virus Subtypes in Liangshan Region， Sichuan Province

Abstract

Abstract: Objective： To understand the characteristics of high-risk human papillomavirus （HR-HPV） infection among women in Liangshan Region， Sichuan Province， and to provide data support for the development and application of HPV vaccine in this area.Methods： The PCR fluorescence probe method was used to detect HR-HPV in 7 445 women who visited the physical examination center of Xichang People's Hospital and the outpatient department of obstetrics and gynecology from November 14，2018 to December 30，2020， and the detection results were statistically analyzed. Results：Among the 7 445 samples， 1 027 were HR-HPV positive， with a positive rate of 13.79%， and all 15 HR-HPV subtypes were detected. Among them， 818 cases （79.65%） were single infection， and 209 cases （20.35%） were multiple infection. The top three subtypes of HR-HPV infection were HPV 52， 16 and 53. In all age groups， the positive rate of subjects aged ≥ 61 years was the highest （22.39%）， followed by subjects aged 21-30 years （15.86%）. Conclusion： The distribution of HR-HPV subtype infection in Liangshan Region， Sichuan Province has certain regional characteristics， and the positive rate is the highest among people over 61 years old. Therefore， it is necessary to strengthen the publicity of HR-HPV screening among the suitable age population.

Key words: font-family:Times New Roman, ">high-risk human papilloma virusfont-family:Times New Roman, ">, font-family:Times New Roman, "> PCR fluorescence probe methodfont-family:Times New Roman, ">, font-family:Times New Roman, "> cervical carcinoma

CLC Number:

Chen Huaqiu, Chen Xingyou, Wang Guangming.

Study of the Distribution of High-Risk Human Papilloma Virus Subtypes in Liangshan Region， Sichuan Province [J]. Journal of Dali University, 2023, 8(2): 51-55.

References

〔1〕 BUSKWOFIE A， DAVID-WEST G， CLARE C A. A Review of Cervical Cancer： Incidence and Disparities〔J〕. J Natl Med Assoc，2020，112（2）：229-232.

〔2〕 COHEN P A， JHINGRAN A， OAKNIN A， et al. Cervical Cancer〔J〕. Lancet，2019，393（10167）：169-182.

〔3〕 ARBYN M， WEIDERPASS E， BRUNI L， et al. Estimates of Incidence and Mortality of Cervical Cancer in 2018： A Worldwide Analysis〔J〕. Lancet Glob Health，2020，8（2）：e191-e203.

〔4〕 SUNG H， FERLAY J， SIEGEL R L， et al. Global Cancer Statistics 2020： GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries〔J〕. CA Cancer J Clin，2021，71（3）：209-249.

〔5〕 SIEGEL R L， MILLER K D， FUCHS H E， et al. Cancer Statistics， 2021〔J〕. CA Cancer J Clin，2021，71（1）：7-33.

〔6〕 MA S， WANG J， HAN Y， et al. Platinum Single-Agent vs. Platinum-Based Doublet Agent Concurrent Chemora-diotherapy for Locally Advanced Cervical Cancer： A Meta-Analysis of Randomized Controlled Trials〔J〕. Gynecol Oncol，2019，154（1）：246-252.

〔7〕 HOU P， HSIEH C， WEI M， et al. Differences in Treatment Outcomes and Prognosis between Elderly and Younger Patients Receiving Definitive Radiotherapy for Cervical Cancer〔J〕. Int J Environ Res Public Health，2020，17（12）：4510.

〔8〕 YIN G， ZHANG Y， CHEN C， et al. Have You ever Heard of Human Papillomavirus （HPV） Vaccine? The Awareness of HPV Vaccine for College Students in China Based on Meta-Analysis〔J〕. Hum Vaccin Immunother，2021，17（8）：2736-2747.

〔9〕 GE Y， ZHONG S， REN M， et al. Prevalence of Human Papillomavirus Infection of 65， 613 Women in East China〔J〕. BMC Public Health，2019，19（1）：178.

〔10〕 OKUNADE K S. Human Papillomavirus and Cervical Cancer〔J〕. J Obstet Gynaecol，2020，40（5）：602-608.

〔11〕 MADHIVANAN P， KRUPP K， COUDRAY M， et al. Longitudinal Assessment of Nonavalent Vaccine HPV Types in a Sample of Sexually Active African American Women from Ten US Cities〔J〕. Vaccine，2021，39（34）：4810-4816.

〔12〕 PLESA A， SOCOLOV D， HUICA I， et al. High-Risk Human Papillomaviruses Distribution in Romanian Women with Negative Cytology〔J〕. J Infect Dev Ctries，2019，13（4）：326-333.

〔13〕 CANFELL K， KIM J J， BRISSON M， et al. Mortality Impact of Achieving WHO Cervical Cancer Elimination Targets： A Comparative Modelling Analysis in 78 Low-Income and Lower-Middle-Income Countries〔J〕. Lancet，2020，395（10224）：591-603.

〔14〕张韶凯，罗喜平，李志芳，等.人乳头瘤病毒分型检测在宫颈癌前病变和宫颈癌筛查中的应用价值〔J〕.中华肿瘤杂志，2020，42（3）：252-256.

〔15〕 LI J， GAO J J， LI N， et al. Distribution of Human Papillomavirus Genotypes in Western China and Their Association with Cervical Cancer and Precancerous Lesions〔J〕. Arch Virol，2021，166（3）：853-862.

〔16〕 OBEIDAT B， MATALKA I， MOHTASEB A， et al. Prevalence and Distribution of High-Risk Human Papi-llomavirus Genotypes in Cervical Carcinoma， Low-Grade， and High-Grade Squamous Intraepithelial Lesions in Jordanian Women〔J〕. Eur J Gynaecol Oncol，2013，34（3）：257-60.

〔17〕 GUPTA B， SUNNAM L B， KUMAR A， et al. Prevalence of Human Papillomavirus 16 Genotype in Anuppur District， Madhya Pradesh〔J〕. Mol Biol Rep，2021，48（1）：503-511.

〔18〕 MOLINA-PINEDA A， L?譫PEZ-CARDONA M G， LIM?譫N-TOLEDO L P， et al. High Frequency of HPV Genotypes 59， 66， 52， 51， 39 and 56 in Women from Western Mexico〔J〕. BMC Infect Dis，2020，20（1）：889.

〔19〕 MINHAS S， KASHIF M， REHMAN Z， et al. Distribution of High-Risk Human Papillomavirus Geno-types in Cervical Secretions in Punjab〔J〕. J Coll Physi-cians Surg Pak，2021，30（7）：786-791.

〔20〕 YUAN X W， LI Y J， QIU Q， et al. Prevalence and Genotype Distribution of Human Papillomavirus among 9945 Women from the Nanhai Area of Foshan〔J〕. BMC Infect Dis，2019，19（1）：71.

〔21〕杨惠霞，韩肖燕，林宇庚，等.高危型人乳头瘤病毒与宫颈病变的相关性分析〔J〕.中国医刊，2020，55（1）：68-71.

〔22〕张勤，王冬.高危型HPV感染在宫颈癌前病变、宫颈癌中的临床意义〔J〕.现代肿瘤医学，2020，28（5）：788-791.

〔23〕 SONG L， LYU Y， DING L， et al. Prevalence and Genotype Distribution of High-Risk Human Papilloma-virus Infection in Women with Abnormal Cervical Cytology： A Population-Based Study in Shanxi Province， China〔J〕. Cancer Manag Res，2020，12：12583-12591.

〔24〕 LI L， CHEN Y， CHEN J， et al. Prevalence and Genotype Distribution of High-Risk Human Papilloma-virus among Chinese Women in Sichuan Province〔J〕. Jpn J Infect Dis，2020，73（2）：96-101.

〔25〕 HE L， HE J. Distribution of High-Risk HPV Types among Women in Sichuan Province， China： A Cross-Sectional Study〔J〕. BMC Infect Dis，2019，19（1）：390.

[1]	Ma Yongjie, Li Weiqi, Wu Chunting, Huang Xinhui, Zhou Xinyu, Ya Fuli, . The Protective Effect and Mechanism of Panax notoginseng Saponins on ox-LDL-Induced Platelet Apoptosis [J]. Journal of Dali University, 2023, 8(2): 1-7.
[2]	Zhu Qianwei, Yang Hua, Qian Kai, Li Dan, Xia Conglong. Study on the Mechanism of Compound Longxuejie Capsules in Treating Coronary Heart Disease Based on Network Pharmacology and Molecular Docking [J]. Journal of Dali University, 2023, 8(2): 8-18.
[3]	He Siyue, Tang Ziyun, Liu Heng, Zhang Chenggui, Zhou Wen, Bi Ziying, Zhou Yue. Inhibition of K562 Cell Proliferation by p53 Protein Regulated by Periplaneta americana Extract CⅡ-3 [J]. Journal of Dali University, 2023, 8(2): 19-23.
[4]	Li Weiqian, Chen Yiming, Zhang Wenting, Su Yingzhen, Shuai Hongyan, Yu Xin. Bioinformatics-Ｂased Analysis and Screening of Differentially Expressed Genes in Pancreatic Cancer [J]. Journal of Dali University, 2023, 8(2): 24-30.
[5]	Cheng Mingjing, Yan Ping, Fan Yujuan, Zhao Weidong. Bioinformatic Analysis of Differentially Expressed Genes in the Patients Infected with Helicobacter pylori [J]. Journal of Dali University, 2023, 8(2): 31-35.
[6]	Yao Qiuyan, Wu Zesheng, Shi Rognjie, Yang Liwei. Analysis of Short-Term Prognostic Factors in Alcoholic Liver Disease-Related Acute-on-Chronic Liver Failure [J]. Journal of Dali University, 2023, 8(2): 36-41.
[7]	Song Qiuling, Dai Jiao. The Expression of Serum Progranulin in Patients with Graves Disease and Its Correlation with IL-17 and IL-10 [J]. Journal of Dali University, 2023, 8(2): 42-45.
[8]	Cheng Wei, Shi Haibin, Cun Xiangnong, Ai Kewei, Fan Jiaju, Yang Jiwu. A Comparative Study of the Clinical Efficacy of Endoscopic Thyroidectomy via the Thoracic-Breast Approach and Open Thyroidectomy [J]. Journal of Dali University, 2023, 8(2): 46-50.
[9]	Tian Tian, Yan Jing, Dai Jiao. Changes of MiR-1281 and MiR-122 in Peripheral Blood of DR Patients and Their Relationship with the Severity of Retinopathy [J]. Journal of Dali University, 2023, 8(2): 56-61.
[10]	Sun Xiaomei, Mei Wen, He Bing, Luo Zhonggui, Sun Ruli, Xiong Wei, Zhao Yi. Expression and Prognostic Significance of Ki-67， Bcl-6， Bcl-2 and TEFM in Diffuse Large B Cell Lymphoma [J]. Journal of Dali University, 2023, 8(2): 62-69.
[11]	Xia Wangxu, He Yongfang, Chen Xiaobo, Huang Chuanfen. The Value of Quantitative CT in Bone Mineral Density Measurement of Patients with Chronic Kidney Disease [J]. Journal of Dali University, 2023, 8(2): 70-73.
[12]	Dong Liwen, Wang Caihong, Zou Tuanbiao. Comparison of Three Detection Methods for Urinary Sediment [J]. Journal of Dali University, 2023, 8(2): 74-77.
[13]	Ni Zhaolin, Zuo Shunwu, Liu Hongyan, Ai Zhiqiong, Nong Luming, Zhao Qiufang, Wu Qiang. Epidemiological Characteristics and Trend Prediction of Influenza in Yuxi City from 2010 to 2019 [J]. Journal of Dali University, 2023, 8(2): 78-83.
[14]	Miao Zhifei, Huang Zhaodan, Chen Yanqing, Chang Yanping. Application of Drawing the Vascular Site Map under B-Ultrasound in Rope Ladder Puncture [J]. Journal of Dali University, 2023, 8(2): 84-87.
[15]	Zhu Xiaoli, Shi Tingting, Zhang Likun, Wei Yanni, Li Ting, Zhang Xiaoling. Application Analysis of Individualized Follow-Up Guidance Based on Network Platform in Patients with Basal Insulin [J]. Journal of Dali University, 2023, 8(2): 88-92.

Study of the Distribution of High-Risk Human Papilloma Virus Subtypes in Liangshan Region， Sichuan Province

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments